Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Information - Accrued Expenses (Details)

v3.22.2
Balance Sheet Information - Accrued Expenses (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Balance Sheet Information    
Executive Severance $ 1,049,808 $ 200,605
Payroll and Benefits 336,680 737,365
Professional Fees 384,452 194,425
Clinical Trials 61,994 168,785
Other   28,961
Total Accrued Expenses $ 1,832,934 $ 1,330,141